Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle

Status

Withdrawn

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00404937

Enrollment

Registered

2006-11-29

Start date

2006-12-31

Completion date

2006-12-31

Last updated

2012-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-surgical Inflammation

Brief summary

The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation

Interventions

DRUGTobradex (Antibiotic steroid combination)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients scheduled for cataract extraction

Exclusion criteria

* Under 18 years

Design outcomes

Primary

Measure	Time frame
Anterior chamber inflammation	—

Secondary

Measure	Time frame
Aqueous cells and flare	—
ocular pain	—
physician's impression of infection	—
frequency of treatment failures	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026